The following pages link to Jennifer Brennan (Q139363):
Displayed 7 items.
- Development of a dual luciferase activity and fluorescamine protein assay adapted to a 384 micro-well plate format: Reducing variability in human luciferase transactivation cell lines aimed at endocrine active substances (Q145606) (← links)
- Comparison of two estrogen chemically activated luciferase expression cell bioassays to liquid chromatography–mass spectrometry for quantifying estrone in water samples (Q150107) (← links)
- Factors affecting sampling strategies for design of an effects‐directed analysis for endocrine‐active chemicals (Q157615) (← links)
- Biological effects of hydrocarbon degradation intermediates: Is the total petroleum hydrocarbon analytical method adequate for risk assessment? (Q300745) (← links)
- Dissolved organic carbon, total petroleum hydrocarbons and and toxicity assay results for Bemidji, MN (2018) (Q323589) (← links)
- Quantitation of estrogens in water, alone and in combination with atrazine, using two chemically-activated luciferase expression, CALUX, bioassays and quadrupole-time of flight ultraperformance liquid chromatography/mass spectrometry, UPLC-MS (Q324855) (← links)
- Development of a dual luciferase-fluorescamine assay adapted to a 384 micro-well plate format-Data (Q329602) (← links)